Bimonthly injections of ranibizumab for age-related macular degeneration

被引：1
|
作者：
Ilhan, Abdullah [1 ,5 ]
Tas, Ahmet [2 ]
Yolcu, Umit [3 ]
Gundogan, Fatih C. [4 ]
机构：
[1] Erzurum Mil Hosp, Dept Ophthalmol, Erzurum, Turkey
[2] Agri Mil Hosp, Dept Ophthalmol, Agri, Turkey
[3] Sarikamis Mil Hosp, Dept Ophthalmol, Kars, Turkey
[4] Gulhane Mil Med Acad, Dept Ophthalmol, Ankara, Turkey
[5] Erzurum Asker Hastanesi, Goz Hastaliklari Klin, TR-25080 Erzurum, Turkey
来源：
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2015年 / 253卷 / 05期
关键词：
Correlation Analysis; Visual Acuity; Slow Rate; Small Decrease; Ranibizumab;
D O I：
10.1007/s00417-014-2877-y
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：823 / 823
页数：1
相关论文
共 50 条
  • [21] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [22] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [23] Treatment of age-related macular degeneration: focus on ranibizumab
    Spitzer, Martin S.
    Ziemssen, Focke
    Bartz-Schmidt, Karl U.
    Gelisken, Faik
    Szurman, Peter
    CLINICAL OPHTHALMOLOGY, 2008, 2 (01): : 1 - 14
  • [24] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [25] Clinical safety of ranibizumab in age-related macular degeneration
    Schmidt-Erfurth, Ursula
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 149 - 165
  • [26] The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
    Tufail, Adnan
    Xing, Wen
    Johnston, Robert
    Akerele, Toks
    McKibbin, Martin
    Downey, Louise
    Natha, Salim
    Chakravarthy, Usha
    Bailey, Clare
    Khan, Rehna
    Antcliff, Richard
    Armstrong, Stewart
    Varma, Atul
    Kumar, Vineeth
    Tsaloumas, Marie
    Mandal, Kaveri
    Bunce, Catey
    OPHTHALMOLOGY, 2014, 121 (05) : 1092 - 1101
  • [27] A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration
    Dae Hyun Park
    Hae Jung Sun
    Sung Jin Lee
    International Ophthalmology, 2017, 37 : 1205 - 1214
  • [28] Impact of Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration on Eyes With Intermediate Age-Related Macular Degeneration
    Chan, Clement K.
    Beaulieu, Wesley T.
    Lujan, Brandon J.
    Lalezary, Maziar
    Lent-Schochet, Daniella
    Lo, Therlinder
    Yiu, Glenn
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2023, 12 (09):
  • [29] Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration
    Urban, Beata
    Szwabowicz, Magdalena
    Bakunowicz-Lazarczyk, Alina
    JOURNAL OF OPHTHALMOLOGY, 2020, 2020
  • [30] Angiographic Regression Patterns After Intravitreal Ranibizumab Injections for Neovascular Age-Related Macular Degeneration
    Thi Ha Chau Tran
    Querques, Giuseppe
    Forzy, Gerard
    Souied, Eric H.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2011, 42 (06) : 498 - 508
12345